During the past decade, Mathias Violante Mélega conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mathias Violante Mélega" are "Endophthalmitis" (2 trials), "Cataracts Infantile" (1 trials) and "Suture, Complication" (1 trials). Many other conditions were trialed in "Mathias Violante Mélega" in a lesser frequency.

Most popular intervention types in "Mathias Violante Mélega" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Moxifloxacin" (1 trials), "No injection of moxifloxacin" (1 trials), "Nylon suture" (1 trials) and "Vicryl suture" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mathias Violante Mélega" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mathias Violante Mélega". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Mathias Violante Mélega, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mathias Violante Mélega, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".